Clinical polyneuropathy does not increase with prediabetes or metabolic syndrome in the Japanese general population-Reference-Cited by-同舟云学术

Clinical polyneuropathy does not increase with prediabetes or metabolic syndrome in the Japanese general population

Published:2019-05-14 Issue:6 Volume:10 Page:1565-1575
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Kurisu Seigo¹²,Sasaki Hideyuki³^ORCID,Kishimoto Shohei²⁴,Hirayasu Kazuhiro¹,Ogawa Kinichi⁵,Matsuno Shohei²,Furuta Hiroto²^ORCID,Arita Mikio⁶,Naka Keigo⁴,Nanjo Kishio⁴,Akamizu Takashi²

Affiliation:

1. Department of Medicine Kihoku HospitalWakayama Medical UniversityWakayamaJapan

2. First Department of MedicineWakayama Medical University Wakayama Japan

3. Division of Diabetes and Metabolism Satellite Clinic for Integrative and Anti‐Aging Medicine Wakayama Medical University WakayamaJapan

4. Wakayama Rosai Hospital WakayamaJapan

5. Kansai University of Health Sciences Osaka Japan

6. Health‐promotion Research Center Wakayama Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13058

Reference27 articles.

1. The epidemiology and risk factors of chronic polyneuropathy

2. Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy

3. Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

4. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

5. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Medical Check-up Programs in Screening Healthy, Asymptomatic Individuals: A Cross-Sectional Study;Medical Records;2023-10-19

2. Neuropathy in prediabetes;Diabetes/Metabolism Research and Reviews;2023-07-20

3. Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-11

4. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments;The Lancet Neurology;2022-10

5. The role of glycation end products in the development and progression of diabetic neuroarthropathy;Problems of Endocrinology;2021-07-22